55 related articles for article (PubMed ID: 1243577)
41. [Centroblastic and centrocytic centroblastic malignant lymphomas, predominantly splenic (or primary of the spleen). Anatomo-clinical study of 17 cases].
Diebold J; Kanavaros P; Audouin J; Bernadou A; Zittoun R
Bull Cancer; 1987; 74(4):437-53. PubMed ID: 3663966
[TBL] [Abstract][Full Text] [Related]
42. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
[TBL] [Abstract][Full Text] [Related]
43. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
44. [Lymph node localization of epidermotropic T malignant lymphomas (mycosis fungoides and Sézary's syndrome)].
Wechsler J; Diebold J; Gérard-Marchant R
Bull Cancer; 1984; 71(2):89-99. PubMed ID: 6610451
[TBL] [Abstract][Full Text] [Related]
45. [Lymphoblastif lymphoma (contribution to its prognosis)].
Nudenberg B; Feijóo F; Laterza A; Dasso N
Med Cutan Ibero Lat Am; 1975; 3(1):69-72. PubMed ID: 1243577
[TBL] [Abstract][Full Text] [Related]
46. Primary cutaneous Richter syndrome: prognostic implications and review of the literature.
Yamazaki ML; Lum CA; Izumi AK
J Am Acad Dermatol; 2009 Jan; 60(1):157-61. PubMed ID: 19103370
[TBL] [Abstract][Full Text] [Related]
47. [Primary non-Hodgkin's lymphoma of the liver: report of two cases and review of the literature].
Pereira FE; Gonçalves CS; Musso C; de Menezes TM; Boni ES
Arq Gastroenterol; 1993; 30(1):27-32. PubMed ID: 8240061
[TBL] [Abstract][Full Text] [Related]
48.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
49.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
